Supplemental Annuity Collective Trust (SACT) of New Jersey’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
+1,900
| New | +$216K | 0.06% | 196 |
|
|
2025
Q1 | – | Sell |
-1,900
| Closed | -$204K | – | 212 |
|
|
2024
Q4 | $204K | Buy |
+1,900
| New | +$204K | 0.06% | 206 |
|
|
2022
Q2 | – | Sell |
-3,046
| Closed | -$214K | – | 223 |
|
|
2022
Q1 | $214K | Hold |
3,046
| – | – | 0.07% | 216 |
|
|
2021
Q4 | $293K | Hold |
3,046
| – | – | 0.09% | 205 |
|
|
2021
Q3 | $265K | Hold |
3,046
| – | – | 0.09% | 203 |
|
|
2021
Q2 | $249K | Hold |
3,046
| – | – | 0.08% | 206 |
|
|
2021
Q1 | $290K | Buy |
+3,046
| New | +$290K | 0.1% | 202 |
|
|
2020
Q3 | – | Sell |
-3,046
| Closed | -$213K | – | 217 |
|
|
2020
Q2 | $213K | Sell |
3,046
-3,206
| -51% | -$224K | 0.1% | 197 |
|
|
2020
Q1 | $284K | Hold |
6,252
| – | – | 0.16% | 167 |
|
|
2019
Q4 | $407K | Hold |
6,252
| – | – | 0.17% | 175 |
|
|
2019
Q3 | $388K | Sell |
6,252
-1,763
| -22% | -$109K | 0.18% | 177 |
|
|
2019
Q2 | $571K | Hold |
8,015
| – | – | 0.25% | 133 |
|
|
2019
Q1 | $629K | Buy |
+8,015
| New | +$629K | 0.28% | 121 |
|